safety study of robotic surgery using DaVinci surgical system in Otolaryngology

safety study of trans oral robotic surgery using DaVinci surgical system in Otolaryngology. - safety study of trans oral robotic surgery using DaVinci surgical system

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040908

Enrollment

Registered

2026-03-31

Start date

2020-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resectable T1/T2 oropharyngeal cancer or supraglottic cancer or benign tumor in oropharynx or larynx

Interventions

trans oral surgery with DaVinci surgical system

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Resectable T1/T2 oropharyngeal cancer or supraglottic cancer or benign tumor in oropharynx or larynx. 1) under 20 years old 2) respectable case from February 1, 2019 to March 31, 2021 at Nagoya university hospital 3) No history of radiation therapy 4) No history of chemotherapy or radiation therapy for head and neck cancer except for tongue cancer 5) No history of chemotherapy or radiation therapy for other cancer 6) No simultaneous or metachronism head and neck cancer

Exclusion criteria

Exclusion criteria: 1) Minor 2) Infectious diseases needed systemic treatment 3) simultaneous or metachronism cancer 4) Fever over 38 degrees 5) pregnant or may be pregnant 6) depression or psychosis 7) unstable angina 8) caa not obtain consent

Design outcomes

Primary

Measure	Time frame
operation time, intra-operative bleeding, Postoperative complication, length of hospital stay	—

Countries

Japan

Contacts

Public Contacttakashi Maruo

nagoya university hospital Otolaryngology

tmaruo@med.nagoya-u.ac.jp052-744-2323

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026